Healthy Living Maine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maine.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 11, 2026

Mar. 11, 2026

Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone

GlobeNewswire

Mar. 11, 2026

24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making

GlobeNewswire

Mar. 11, 2026

Clearmind Medicine Advances Recruitment for CMND-100 Trial's Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline Results

GlobeNewswire

Mar. 11, 2026

KOMO Biosciences Grants Research Evaluation License to Syngenta to Explore Precision Genome Modification in Maize

GlobeNewswire

Mar. 11, 2026

New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder

GlobeNewswire

Mar. 11, 2026

Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study

GlobeNewswire

Mar. 11, 2026

Sleep.ai and HearMe Redefine Human-Centered Mental Health Support with Embedded Sleep Intelligence

GlobeNewswire

Mar. 11, 2026

Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program

GlobeNewswire

Mar. 11, 2026

Weight Watchers Report Finds Integrated GLP-1 Support Drives Significantly Greater Weight Loss Than Medication Alone

GlobeNewswire

Mar. 11, 2026

Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock

GlobeNewswire

Mar. 11, 2026

BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform

GlobeNewswire

Mar. 11, 2026

Autonomix Medical to Present at LSI USA ’26

GlobeNewswire

Mar. 11, 2026

Pelvic Rehabilitation Medicine Expands to San Antonio, Launching Endometriosis Center of Excellence

GlobeNewswire

Mar. 11, 2026

ORAGENICS EXPLORES EXPANSION OF CNS PLATFORM PURSUING ACQUISTION OF ASSETS IN BRAIN HEALTH, RECOVERY, AND NEUROPROTECTION

GlobeNewswire

Mar. 11, 2026

Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome

GlobeNewswire

Mar. 11, 2026

NurExone Announces Corporate Updates

GlobeNewswire

Mar. 11, 2026

SCIENTURE Broadens Commercial Access for REZENOPY™, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions

GlobeNewswire

Mar. 11, 2026

George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea

GlobeNewswire

Mar. 11, 2026

Respiratory Medicine Publishes MATCH 2 Study Demonstrating Reliability of Real-Time Imaging Guidance in Robotic Bronchoscopy

GlobeNewswire

Mar. 11, 2026

Community Care Cooperative (C3) Earns $10.2 Million in Shared Savings Through Medicare Shared Savings Program (MSSP) Track A for Performance Year 2024

GlobeNewswire